Showing posts with label LISTS OF TERATOGENIC AND FETOTOXIC DRUGS. Show all posts
Showing posts with label LISTS OF TERATOGENIC AND FETOTOXIC DRUGS. Show all posts

Monday, April 27, 2009

LIST OF DRUGS ADVERSE EFFECTS ON FETUS

LIST OF DRUGS WITH SIGNIFICANT ADVERSE EFFECTS ON THE FETUS.
[TERATOGENIC AND FETOTOXIC DRUGS]









The lists adverse drugs consist of: Name of drugs; Trimester adverse [T1 is first trimester, T2 is second, T3 is third, T-all is all trimester] respectively; Effect [E];and Indications [I].





Your Ad Here


ACE [Angiotensin-converting enzyme]inhibitor; T-all especially second and third; E: Renal damage; I: Essential hypertension.
Aminopterin; T1; E: Multiple gross anomalies .
Amphetamines: T-all; E: Suspected abnormal developmental patterns, decreased school performance I: Narcolepsy.
Androgens; T2, T3; E: Masculinization of female fetus; I: Osteoporosis, aging.
Anti depressants, tricyclic; T3; E: Neonatal withdrawal symptoms have been reported in a few cases with clomipramine, desipramine, and imipramine; I: Antihistamine,antidepressant.
Barbiturate; T-all; E: Chronic use can lead to neonatal dependence; I: Sedation, anti-convulsants.
Busulfan; T-all; E: Various congenital malformations, low birth weight; I: Chronic myelogenous leukemia.
Carbamazepine; T1; E: Neural tube defects; I: Partial and tonic-clonic seizures, mania
Chlorpropamide; T-all; E: Prolonged symptomatic neonatal hypoglycemia; I: Diabetes mellitus.
Clomipramine; T3; E: Neonatal lethargy, hypotonia, cyanosis, hypothermia; I: Antidepressants.
Cyclophosphamide; T1; E: Various congenital malformation; I: Rheumatoid arthritis.
Cytarabine; T1, T2; E: Various congenital malformation; I: Acute myelogenous leukemia.
Diazepam; T-all; E: Chronic use may lead to neonatal dependence; I: Sedations, spasmolytics.
Diethylstilbestrol; T-all; E: Vaginal adenosis, clear cell vaginal adeno-carcinoma; I: Postcoital contraceptives.
Etretinate; T-all; E: High risk of multiple congenital malformation; I: Vitamin A analogs.
Iodide; T-all; E: Congenital goiter, hypothyroidism; I: Antithyroid agents.
Isotretinoin; T-all: E: Extremely high risk of CNS [central nervous system], face ear, and other malformations; I: Severe cystic acne.
Lithium; T1; E: Ebstein’s anomaly or cardiac anomaly; I: Anti manic-depressive.
Methotrexate: T1: E: Multiple congenital malformations; I: Rheumatoid artrhitis.
Methylthiouracil: T-all: E: Hypothyroidism; I: Cancer chemotherapy.
Metronidazole; T1: May be mutagenic [from animal studies; there is no evidence for mutagenic or teratogenic effects in humans]; I: Amebiasis, trichomoniasis.
Misoprostol; T1; E: Mobius sequence, cramping abdominal pain, and stimulate uterine contraction may induce abortion; I: Peptic ulcer.
Penicillamine: T1; E: Cutis laxa [loose skin], other congenital malformations; I: Severe rheumatoid arthritis.
Phencyclidine: T-all; E: Abnormal neurologic examination, poor suck reflex and feeding; I: General anasthetics.
Phenytoin; T-all; E: Fetal hydantoin syndrome, congenital malformations, spina bifida [spinal column malformation]; I: Partial and generalized tonic-clonic seizures.
Propylthiouracil; T-all; E: Congenital goiter; I: Thyrotoxicosis.
Sterptomycin; T-all; E: Eighth nerve toxicity, deafness; I: Tuberculosis.
Tamoxifen; T-all; E: Increased risk of spontaneous abortion or fetal damage; I: Breast cancer, chemo-prevention breast cancer.
Tetracycline; T-all; E: Discoloration and defects of teeth and altered bone growth; I: Broadspectrum bacteriostatic and antibiotics.
Thalidomide; T1: E: Phocomelia [shortened or absent long bones of the limbs] and many internal malformations ; I: Multiple myeloma, lupus erythematosus.
Trimethadione; T-all; E: Multiple congenital anomalies; I: Anti seizure, sedation.
Valproic acid; T-all; E: Neural tube defects, cardiac and limb malformations; I: Against absence [prevention] seizures, migraine.
Warfarin; T1; E: hypoplastic nasal bridge, chondrodysplasia; T2, E: CNS malformations; T3, E: Risk of bleeding. Discontinue use one month before delivery; I: Anticoagulants.

Source: Bertram G. Katzung, MD, PhD. Basic and Clinical Pharmacology, McGraw-Hill,California, 2007, p 975-76.

Note: The writer adds Indication [I] to the list of the source for "warning" the physicians and the patients ; for treatment of patients as indicated the above list of drugs are contra-indicated for pregnant women, particularly in trimester concern. Please be careful.

Good luck,have a nice treatments of diseases have been indicated!!!